Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome [NA]

View source ↗

Summary

The document reports the completion of a clinical trial evaluating the effect of nicotinamide mononucleotide (NMN) on Polycystic Ovary Syndrome conducted by Pek…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Mononucleotide (nicotinamide mononucleotide)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Polycystic Ovary Syndrome | NA | Status: COMPLETED